Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
J Agric Food Chem ; 71(20): 7937-7946, 2023 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-37166010

RESUMEN

Comprehensive screening for functional substances from natural resources is always a hot research topic. Eicosapentaenoic acid- (EPA) and docosahexaenoic acid (DHA)-structured phospholipids (PLEPA/DHA) have versatile cardiovascular benefits as well as superior bioavailability. Herein, the abundance of PLEPA/DHA in 16 aquatic products was specifically and selectively screened using a recently developed precursor ion scan-driven hydrophilic interaction chromatography-mass spectrometry (PreIS-HILIC/MS) method with the fatty acyl moieties of EPA (m/z 301.6) and DHA (m/z 327.6) locked. The aim focused on the characteristics and differences in the varieties and contents of EPA/DHA-structured phosphatidylcholine (PCEPA/DHA) and EPA/DHA-structured phosphatidylethanolamine (PEEPA/DHA) molecular species. A total of 80 PLEPA/DHA molecules were identified in these natural sources, including 47 PCEPA/DHA and 33 PEEPA/DHA. After analysis, PC 16:0/20:5 and PC 16:0/22:6 are present in all aquatic products and at high levels. Antarctic krill was found to be the best resource of PLEPA/DHA in total (2574.69 µg·g-1), followed by mackerel (2330.11 µg·g-1), salmon (2109.91 µg·g-1), and Farrer's scallop (1883.59 µg·g-1), while abalone contained the lowest level of PLEPA/DHA (310.44 µg·g-1). Besides, sea cucumber and sea bass contained the highest contents of EPA-structured and DHA-structured ether phospholipids, respectively, which could be highly recommended as dietary sources of special functional phospholipids. Finally, the multiple discrepancies between the 16 aquatic products were revealed by multivariate statistical analysis. These findings improve the awareness of the composition and content of PLEPA/DHA contained in aquatic products, providing a reference for their integrated development.


Asunto(s)
Ácido Eicosapentaenoico , Fosfolípidos , Ácido Eicosapentaenoico/química , Fosfolípidos/química , Ácidos Docosahexaenoicos , Espectrometría de Masas en Tándem , Lecitinas
2.
Biol Trace Elem Res ; 201(5): 2365-2376, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-35759081

RESUMEN

Selenium (Se), as a trace element, is widely found in animals in the form of selenomethionine, which can provide nutrition to the body and has anti-inflammatory effects to prevent inflammatory damage in animals. In the past decade, there have been many studies on piglet diseases caused by selenium deficiency; however, under Se deficiency, the relationship between LncRNA-MORC3, inflammatory injury, and tight junctions in piglets has not yet been studied. We established piglet selenium deficiency models divided into three groups and obtained small intestinal tissues after 35 days of feeding. Small intestinal epithelial IPEC-J2 cells were divided into three groups, and samples were collected after 24 h of culture for qPCR and Western blot experiments. First, we found that Se deficiency led to an increase in LncRNA-MORC3 expression in piglets in vivo and in vitro. We found that the binding site of NLRP3 on LncRNA-MORC3 and the expression trends of both were the same: Se deficiency increased the secretion of NLRP3 and the expression levels of the inflammatory factors Caspase-1, ASC, IL-1ß, IL-17, IL-6, IL-10, and TNF-α, which are related to the NLRP3-Caspase-1/IL-1ß signaling pathway. At the same time, Se deficiency decreased the expression levels of the tight junction factors ZO-1, Z0-2, Occludin, E-cadherin, and ZEB-1. This result showed that the tight junctions were disrupted. Herein, we demonstrated that Se deficiency promotes the expression of both LncRNA-MORC3 and inflammatory factors in piglets to activate the NLRP3-Caspase-1/IL-1ß signaling pathway and disrupt tight junctions. Ultimately, these factors lead to inflammatory damage in piglet small intestinal tissues.


Asunto(s)
ARN Largo no Codificante , Selenio , Animales , Porcinos , Proteína con Dominio Pirina 3 de la Familia NLR/genética , Proteína con Dominio Pirina 3 de la Familia NLR/metabolismo , Caspasa 1/genética , Caspasa 1/metabolismo , Inflamasomas , Uniones Estrechas/metabolismo , Transducción de Señal
3.
Electrophoresis ; 41(5-6): 379-385, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-32040861

RESUMEN

Justicia procumbens is a food and medicine homologous variety, popularly used for making vegetable soups. In this study, a novel mesoporous silica was synthesized and used as the sorbent of SPE for the purification of lignans from J. procumbens. A laboratory-made SPE cartridge was packed with 100 mg of mesoporous silica, which was washed with 10% methanol and eluted using 0.8 mL acetonitrile after sample loading. Afterward, the extract was analyzed by ultra-performance liquid chromatography (UPLC) and MS/MS. All the lignans were efficiently separated in 6 min with the noise level in the range of 50-150 cps. 6'-Hydroxy justicidin B, 6'-hydroxy justicidin A, justicidin B, chinensinaphthol methyl ether, justicidin C, and neojusticdin A were identified to be the dominant molecular species in J. procumbens with contents of 0.065-0.37 mg/g in three tested sample batches from different geographic origins. In conclusion, the proposed mesoporous silica based SPE UPLC-MS/MS method is efficient in linearity (R2 = 0.9989-0.9996), sensitivity (LOD ≤0.13 µg/kg and LOQ ≤0.42 µg/kg), precision (RSDintra-day ≤3.12 and RSDinter-day ≤4.56), and recovery (83.42-96.11%, RSD ≤2.88%).


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Género Justicia/química , Lignanos/análisis , Extracción en Fase Sólida/métodos , Espectrometría de Masas en Tándem/métodos , Modelos Lineales , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Dióxido de Silicio/química
4.
Pol J Vet Sci ; 15(3): 547-52, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23214377

RESUMEN

UNLABELLED: The present study was designed to investigate the influence of Se deficiency on serum histamine concentration and the expression of histamine receptor in the jejunum of chickens. Forty neonatal chickens were randomly divided into two groups. Experimental chickens were fed a low-Se diet (0.034 mg/kg), whereas chickens in the control group were fed a diet with a Se level of 0.229 mg/kg. Ten chickens were sacrificed on days 30, 45, 60 and 75. Blood and jejunum samples were collected. Histamine concentration in the jejunum was measured by ELISA, the jejunal mast cell (MC) ultrastructure was studied by transmission electron microscopy, and the expression level of histamine H2 receptor (H2R) mRNA in the jejunum was examined using real-time PCR. RESULTS: The jejunal histamine concentration in chickens fed the low-Se diet was significantly higher than that in the control group (P < 0.01). Se deficiency induced degranulation of MC in the jejunum of chickens in the low-Se diet group; their cytoplasm was filled with fused granules and vacuoles. The expression level of jejunal H2R mRNA in chickens fed the low-Se diet was also significantly higher than that in the control group (P < 0.01). The results obtained suggest that Se deficiency stimulates MC degranulation and release of histamine, binding H2R promotes both regulation of digestion and cell proliferation while protects the jejunum from injury induced by Se deficiency.


Asunto(s)
Pollos/fisiología , Histamina/metabolismo , Yeyuno/fisiología , Receptores Histamínicos H2/metabolismo , Selenio/deficiencia , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Regulación de la Expresión Génica/fisiología , Yeyuno/citología , Mastocitos/ultraestructura , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores Histamínicos H2/genética
6.
J Pharm Pharm Sci ; 14(3): 325-35, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21824448

RESUMEN

PURPOSE. Tryptanthrin, an indole quinazoline alkaloid with multiple medical activities, has been recently under preclinical development as an anti-tuberculosis and anti-tumor drug. The aims of this study are to characterize the intestinal transport of tryptanthrin in Caco-2 cells, to determine whether P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (MRP2) are involved in this issue, and to evaluate the potential influence of tryptanthrin on the function of P-gp and MRP2. METHODS. Transport assays of tryptanthrin were performed in Caco-2 monolayers with or without the supplement of P-gp and MRP2 inhibitors. Transport assays of P-gp and MRP2 substrates were also performed in the presence of tryptanthrin. The effect of tryptanthrin on the expression of P-gp and MRP2 was analyzed by reverse transcriptase-PCR. RESULTS. Both absorption and secretion of tryptanthrin were concentration-independent at a low concentration range of 0.8-20 µM. The apparent permeability (Papp) for the apical (AP) to basolateral (BL) was 6.138 ± 0.291 × 10-5. The ratio of Papp (BL→AP) to Papp (AP→BL) was 0.77, suggesting greater permeability in the absorptive direction. Both the P-gp inhibitor, verapamil, and the MRP2 inhibitor, glibenclamide, didn't affect the efflux transport of tryptanthrin. The efflux transport of the P-gp substrate, digoxin, and the MRP2 substrate, pravastatin sodium, decreased when tryptanthrin was present. However, tryptanthrin didn't change the expression of P-gp and MRP2. CONCLUSIONS. Tryptanthrin was well absorbed across the Caco-2 monolayers, and its transepithelial transports were dominated by passive diffusion. Tryptanthrin was not a substrate, but a potential inhibitor of P-gp and MRP2. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/antagonistas & inhibidores , Antituberculosos/farmacología , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/antagonistas & inhibidores , Quinazolinas/farmacología , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/biosíntesis , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/metabolismo , Antituberculosos/química , Transporte Biológico/efectos de los fármacos , Células CACO-2 , Difusión , Digoxina/farmacología , Evaluación Preclínica de Medicamentos , Medicamentos Herbarios Chinos , Inhibidores Enzimáticos/farmacología , Gliburida/farmacología , Humanos , Hipoglucemiantes/farmacología , Mucosa Intestinal/metabolismo , Intestinos/efectos de los fármacos , Proteína 2 Asociada a Resistencia a Múltiples Medicamentos , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/biosíntesis , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/genética , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/metabolismo , Permeabilidad/efectos de los fármacos , Quinazolinas/química
7.
Sci China Life Sci ; 54(4): 300-10, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21267668

RESUMEN

The causative agent of tuberculosis, Mycobacterium tuberculosis, is one of the most successful of human pathogens. It can evade the host immune response and establish a persistent infection or enter a dormant state within the host which can be reactivated if the host becomes immuno-compromised. Both of these features are major obstacles to tuberculosis eradication. Dormancy and reactivation of M. tuberculosis are tightly coordinated dynamic processes involving numerous genes and their products. Molecular mechanisms underlying M. tuberculosis persistence may provide an opportunity for the discovery of effective drug targets for tuberculosis control. Here, we review the genes required for M. tuberculosis persistence and propose a regulatory network for the action of these genes using text mining. This should provide fresh insights into the persistence mechanisms of M. tuberculosis and suggest candidates for new drug targets and immune intervention.


Asunto(s)
Redes Reguladoras de Genes , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/patogenicidad , Tuberculosis/genética , Tuberculosis/microbiología , Animales , Antituberculosos/uso terapéutico , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Genes Bacterianos , Humanos , Mycobacterium tuberculosis/metabolismo , Tuberculosis/tratamiento farmacológico
8.
Pharmacology ; 85(6): 365-71, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20530976

RESUMEN

BACKGROUND: Due to the long duration of treatment and the emergence of multidrug-resistant strains, new antitubercular agents are urgently needed. I2906, as a novel lead, was screened and tested for efficacy in vitro and in vivo. METHODS: To determine the efficacy of I2906,the minimum inhibitory concentrations against Mycobacterium tuberculosis and cytotoxicity were tested, and its in vivo activities were assessed by administering it to mice infected with M. tuberculosis H37Rv or multidrug-resistant strain. RESULTS: Under in vitro conditions, I2906 showed excellent antimycobacterial activities and low cytotoxicity. In a murine model infected with M. tuberculosis H37Rv, the reductions on bacterial loads of both lungs and spleen were statistically significant (p < 0.05) between I2906-treated mice and untreated controls after 4 weeks. Further, the colony-forming unit counts in the lungs were dramatically lower (p < 0.05) than that of isoniazid-treated mice by the addition of I2906 after 8 weeks. Moreover, survival rate was increased by I2906 treatment. For multidrug-resistant strain infection, bacterial counts were reduced significantly in the lungs and spleen due to I2906 treatment in comparison with data from untreated controls (p < 0.05). CONCLUSIONS: I2906 displayed potential antimicrobial activities against M. tuberculosis H37Rv and drug-resistant strains in vitro and in vivo, and could improve efficacy of isoniazid in vivo.


Asunto(s)
Antituberculosos/uso terapéutico , Hidrazinas/farmacología , Hidrazinas/toxicidad , Mycobacterium tuberculosis/efectos de los fármacos , Quinolonas/farmacología , Quinolonas/toxicidad , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Pulmonar/tratamiento farmacológico , Animales , Antituberculosos/sangre , Antituberculosos/farmacología , Antituberculosos/toxicidad , Línea Celular Tumoral , Recuento de Colonia Microbiana , Evaluación Preclínica de Medicamentos , Femenino , Haplorrinos , Humanos , Hidrazinas/sangre , Isoniazida/farmacología , Isoniazida/uso terapéutico , Pulmón/microbiología , Pulmón/patología , Ratones , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Mycobacterium tuberculosis/crecimiento & desarrollo , Mycobacterium tuberculosis/patogenicidad , Quinolonas/sangre , Bazo/microbiología , Análisis de Supervivencia , Tuberculosis Resistente a Múltiples Medicamentos/microbiología , Tuberculosis Resistente a Múltiples Medicamentos/patología , Tuberculosis Pulmonar/microbiología , Tuberculosis Pulmonar/patología
9.
Bioorg Med Chem Lett ; 19(21): 6074-7, 2009 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-19796945

RESUMEN

In order to identify new and potent candidate drugs to treat tuberculosis, a library of compounds was screened, and (S,S)-N,N'-bis-[3-(2,2',6,6'-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) was identified as a hit in the screen. This research discusses our efforts to synthesize and test 30 analogs of this hit for activity against Mycobacterium tuberculosis. Two compounds with homopiperazine ring possess high in vitro activity against drug sensitive and resistant M. tuberculosis with MICs 0.78-3.13 microg/mL (or 1.22-4.88 microM).


Asunto(s)
Antituberculosos/síntesis química , Azepinas/síntesis química , Compuestos de Bencidrilo/síntesis química , Etilenodiaminas/síntesis química , Tuberculosis/tratamiento farmacológico , Antituberculosos/química , Antituberculosos/toxicidad , Azepinas/química , Azepinas/toxicidad , Compuestos de Bencidrilo/química , Compuestos de Bencidrilo/toxicidad , Evaluación Preclínica de Medicamentos , Farmacorresistencia Bacteriana , Etilenodiaminas/química , Etilenodiaminas/toxicidad , Mycobacterium tuberculosis/efectos de los fármacos
10.
Biochem Biophys Res Commun ; 339(3): 897-904, 2006 Jan 20.
Artículo en Inglés | MEDLINE | ID: mdl-16325768

RESUMEN

Inositol monophosphatase is an enzyme in the biosynthesis of myo-inostiol, a crucial substrate for the synthesis of phosphatidylinositol, which has been demonstrated to be an essential component of mycobacteria. In this study, the Rv2131c gene from Mycobacterium tuberculosis H37Rv was cloned into the pET28a vector and the recombinant plasmid was transformed into Escherichia coli BL21 (DE3) strain, allowing the expression of the enzyme in fusion with a histidine-rich peptide on the N-terminal. The fusion protein was purified from the soluble fraction of the lysed cells under native conditions by immobilized metal affinity chromatography (IMAC). The purified Rv2131c gene product showed inositol monophosphatase activity but with substrate specificity that was broader than those of several bacterial and eukaryotic inositol monophosphatases, and it also acted as fructose-1,6-bisphosphatase. The dimeric enzyme exhibited dual activities of IMPase and FBPase, with K(m) of 0.22+/-0.03mM for inositol-1-phosphate and K(m) of 0.45+/-0.05mM for fructose-1,6-bisphosphatase. To better understand the relationship between the function and structure of the Rv2131c enzyme, we constructed D40N, L71A, and D94N mutants and purified these corresponding proteins. Mutations of D40N and D94N caused the proteins to almost completely lose both the inositol monophosphatase and fructose-1,6-bisphosphatase activities. However, L71A mutant did not cause loss either of the activities, but the activity toward the inositol was 12-fold more resistant to inhibition by lithium (IC(50) approximately 60mM). Based on the substrate specificity and presence of conserved sequence motifs of the M. tuberculosis Rv2131c, we proposed that the enzyme belonged to class IV fructose-1,6-bisphosphatase (FBPase IV).


Asunto(s)
Fructosa-Bifosfatasa/química , Fructosa-Bifosfatasa/metabolismo , Mycobacterium tuberculosis/enzimología , Monoéster Fosfórico Hidrolasas/química , Monoéster Fosfórico Hidrolasas/metabolismo , Secuencia de Aminoácidos , Activación Enzimática , Escherichia coli/enzimología , Escherichia coli/genética , Isoenzimas , Datos de Secuencia Molecular , Peso Molecular , Mycobacterium tuberculosis/genética , Monoéster Fosfórico Hidrolasas/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Homología de Secuencia de Aminoácido
11.
Wei Sheng Wu Xue Bao ; 45(6): 895-9, 2005 Dec.
Artículo en Chino | MEDLINE | ID: mdl-16496699

RESUMEN

Radix Ranuncoli Ternati is clinically effective traditional Chinese medicine for multidrug resistant tuberculosis. Its active components and mechanism of action remain unsolved. Two dimensional gel electrophoresis (2-DE) was employed to address this problem. Globlal proteome of Mycobacterium tuberculosis untreated and treated with Radix Ranuncoli Ternati were compared, and 22 protein spots were found to be expressed differentially. 3 protein spots which remarkably decreased in Mycobacterium tuberculosis treated with Radix Ranuncoli Ternati were subjected to matrix assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS) analysis. The data obtained from peptide mass finger printing were used for database search. The 3 protein spots in gel were identified as cysA2 (thiosulfate sulfurtransferase), tsf (elongation factor EF-Ts) and hspX (heat shock protein X). These data provide insights into the changed global protein patterns of Mycobacterium tuberculosis treated with Radix Ranuncoli Ternati and may prove useful for further study in the mechanism in how Radix Ranuncoli Ternati influence the life of Mycobacterium tuberculosis. The differentially expressed proteins may be potential novel antituberculosis drug targets.


Asunto(s)
Proteínas Bacterianas/análisis , Medicina Tradicional China , Mycobacterium tuberculosis/efectos de los fármacos , Extractos Vegetales/farmacología , Proteoma , Antígenos Bacterianos/análisis , Electroforesis en Gel Bidimensional , Mycobacterium tuberculosis/química , Factor Tu de Elongación Peptídica/análisis , Factores de Elongación de Péptidos/análisis , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción
12.
J Proteome Res ; 3(6): 1201-9, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15595729

RESUMEN

The design and characterization of titania-based and alumina-based Poly(dimethylsiloxane) (PDMS) microfluidics enzymatic-reactors along with their analytical features in coupling with MALDI-TOF and ESI-MS were reported. Microfluidics with microchannel and stainless steel tubing (SST) were fabricated using PDMS casting and O(2)-plasma techniques, and were used for the preparation of an enzymatic-reactor. Plasma oxidation for the PDMS microfluidic system enabled the channel wall of the microfluidics to present a layer of silanol (SiOH) groups. These SiOH groups act as anchors onto the microchannel wall linked covalently with the hydroxyl groups of trypsin-encapsulated sol matrix. As a result, the trypsin-encapsulated gel matrix was anchored onto the wall of the microchannel, and the leakage of gel matrix from the microchannel was effectively prevented. A feature of the microfluidic enzymatic-reactors is the feasibility of performing on-line protein analysis by attached SST electrode and replaceable tip. The success of trypsin encapsulation was investigated by AFM imaging, assay of enzymatic activity, CE detection, and MALDI-TOF and ESI-MS analysis. The lab-made devices provide an excellent extent of digestion even at a fast flow rate of 7.0 microL/min, which affords the very short residence time of ca. 2 s. With the present device, the digestion time was significantly shortened compared to conventional tryptic reaction schemes. In addition, the encapsulated trypsin exhibits increased stability even after continuous use. These features are required for high-throughput protein identification.


Asunto(s)
Enzimas Inmovilizadas/metabolismo , Técnicas Analíticas Microfluídicas/instrumentación , Mapeo Peptídico/métodos , Tripsina/metabolismo , Óxido de Aluminio , Dimetilpolisiloxanos , Electrodos , Diseño de Equipo , Espectrometría de Masas , Técnicas Analíticas Microfluídicas/métodos , Transición de Fase , Proteínas/análisis , Siliconas , Propiedades de Superficie , Titanio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA